Patients with type 2 diabetes display metabolic abnormalities including, hyperglycemia, increase in free fatty acids, and insulin resistance. These metabolic abnormalities induce severe and ultimately detrimental human health issues such as cardiovascular disease and neuropathy. Changes in gene expression is an underlying factor that contributes to the physiological changes associated with diabetes. However, little is understood about how factors such as hyperglycemia or a sugar-supplemented diet impacts gene expression. We use the genetic model Caenorhabditis elegans to study the impact a glucose-supplemented diet has on various biological processes including physiology and gene expression. Previously, we showed that a glucose-supplemented diet increases lipid composition, and significantly alters the transcriptome profile (RNA-sequencing studies). From our transcriptomic analysis, we identified 140 gene expression regulators altered in response to a glucose-supplemented diet. We determined the
acs-2 gene, which encodes an acyl-CoA synthetase, is a glucose-responsive gene; this was shown by RNA-sequencing analysis, the
acs-2::GFPreporter strain, and quantitative RT-PCR. Here, we developed a targeted RNA interference (RNAi) screen to identify the transcriptional regulators that respond to a glucose diet using the
acs-2::GFPreporter strain. We used RNAi to knock-down transcriptional regulators, many of which are known to be differentially expressed by a glucose diet, to identify those that modulate
acs-2 expression in a glucose-supplemented diet dependent manner. In total, we assayed 140 transcriptional regulators. Results from this RNAi screen will be presented. Together, these studies add to our understanding of the physiological, transcriptional, and molecular changes that occur in response to a glucose supplemented diet.